ML221

ML221 is a potent apelin receptor (APJ) functional antagonist in cell-based assays that is >37-fold selective over the closely related angiotensin II type 1 (AT1) receptor. The IC50 values of ML221 are 0.70 and 1.75 μM in a cAMP assay and β-arrestin assay, respectively.

ML221 Chemical Structure

ML221 Chemical Structure

CAS No. 877636-42-5

Purity & Quality Control

Batch: S869501 DMSO]9 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.76%
99.76

ML221 Related Products

Biological Activity

Description ML221 is a potent apelin receptor (APJ) functional antagonist in cell-based assays that is >37-fold selective over the closely related angiotensin II type 1 (AT1) receptor. The IC50 values of ML221 are 0.70 and 1.75 μM in a cAMP assay and β-arrestin assay, respectively.
Targets
apelin receptor [1]
(β-arrestin assay)
1.75 μM
In vitro
In vitro In a PAMPA permeability assay, ML221 exhibits moderate permeability. ML221 displays moderate plasma and poor microsomal stability, as it is rapidly metabolized in both human and mouse liver homogenates (4.2% and 4.9% remaining at 60 min). It shows no toxicity (>50 μM) toward human hepatocytes. ML221 displays limited cross reactivity against a range of GPCRs[1]. ML221 inhibits endothelial cell proliferation by blocking apelin-APJ signaling without affecting the expression of VEGF and VEGFR2[2].
Cell Research Cell lines bEnd.3 cells
Concentrations 0–30 μM
Incubation Time 24 h
Method

The proliferation of bEnd.3 cells following 24 h incubation with ML221 (0-30 μM) are assessed by the MTT assay and the BrdU incorporation assay. Mouse endothelial cell line bEnd.3 cells are maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum. The cells are plated at a density of 2.5 × 104/well in 24 well culture plates for the MTT assay and the BrdU incorporation assay. To perform the BrdU incorporation assay, 10 μM BrdU is added to the culture medium. After 2 h, the cells are fixed with 4% paraformaldehyde for 10 minutes. After removing the 4% paraformaldehyde, the cells are incubated with 2 M hydrochloric acid for 10 min at 37℃ for DNA hydrolysis, followed by neutralization with 0.1 M Sodium Borate buffer (pH 8.5) for 30 min at room temperature. Intranuclear BrdU is labeled with mouse anti-BrdU antibodies. The primary antibody is visualized with biotinylated goat anti-mouse IgG antibodies plus streptavidin fluorescein isothiocyanate. Nuclei are detected with Hoechst33342. The BrdU incorporation rate is determined by calculating the numbers of BrdU positive cells per Hoechst positive cells.

In Vivo
In vivo Intraperitoneal administration of ML221 inhibits pathological angiogenesis but enhances the recovery of normal vessels into the ischemic regions in the retina of the OIR model mice[2]. A single application of ML221 alleviates mechanical allodynia and heat hyperalgesia 7 days following chronic constriction injury (CCI), in a dose‑dependent manner. Intraspinal delivery of ML221, at the onset of and in fully‑established neuropathic pain, persistently attenuates CCI‑induced pain hypersensitivity, indicating that the apelin‑APJ system is involved in initiating and maintaining pain. Intrathecal ML221 downregulates phosphorylated extracellular signal‑related kinase (ERK) in the rat spinal cord dorsal horn, suggesting that the effect of apelin on neuropathic pain may be mediated via ERK signaling[3].
Animal Research Animal Models An ischemic retinopathy mouse model (C57BL/6 N mice)
Dosages 10 mg/kg
Administration i.p.

Chemical Information & Solubility

Molecular Weight 385.35 Formula

C17H11N3O6S

CAS No. 877636-42-5 SDF --
Smiles C1=CN=C(N=C1)SCC2=CC(=O)C(=CO2)OC(=O)C3=CC=C(C=C3)[N+](=O)[O-]
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 9 mg/mL ( (23.35 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy ML221 | ML221 supplier | purchase ML221 | ML221 cost | ML221 manufacturer | order ML221 | ML221 distributor